Clinical Trial: FFA Metabolism in Different Types of Human Obesity


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

FFA Metabolism in Different Types of Human Obesity

This study is currently recruiting patients.

Sponsored by:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

We will give intravenous fat molecules to help us understand how the fat that is released from peoples fat cells is used. This will be done when people are eating, not eating and walking.

Condition
Obesity

MedlinePlus related topics: Obesity

Study Type: Observational
Study Design: Natural History, Cross-Sectional, Defined Population, Prospective Study

Further Study Details:

Expected Total Enrollment: 192

Study start: November 2003; Study completion: November 2008

Eligibility

Ages Eligible for Study: 18 Years - 50 Years, Genders Eligible for Study: Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria: BMI 28-36 -upper body obesity and lower body obesity non-obese BMI 19-24. Females premenopausal. Must be a non-smoker.

Exclusion Criteria: BP> 160/95 on HTN meds, known systemic illness. Medications that affect fat metabolism. We do no cover travel expenses. Known heart and vascular disease.

Location and Contact Information

Minnesota
Mayo Clinic, Rochester, Minnesota, 55905, United States; Recruiting

Michael D Jensen, MD 507-284-2511 jensen@mayo.edu
Carol Siverling, RN 5072842511 siverling.carol@mayo.edu
Christina Koutsari, PhD, Sub-Investigator

More Information

Study ID Numbers: FFAMET
Record last reviewed: October 2004
Record first received: September 10, 2003
ClinicalTrials.gov Identifier: NCT00068900
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-08

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services